# LONG-TERM OUTCOMES OF INTRAVITREAL BEVACIZUMAB THERAPY FOR SUBRETINAL NEOVASCULARIZATION SECONDARY TO IDIOPATHIC MACULAR TELANGIECTASIA TYPE 2

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/long-term-outcomes-of-intravitreal-bevacizumab-therapy-for-subretinal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Okan Toygar,Matthew G. Guess,David S. Youssef,Daniel M. Miller |
| Citations | 24 |
| DOI | 10.1097/iae.0000000000001035 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2409004628 |
| PMID | 27258671 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Okan Toygar](https://scholariq.org/researchers/okan-toygar/)

## Paper journal

- [Retina](https://scholariq.org/journals/retina/)

## Paper primary topic

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

## Paper topics

- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)
- [Retinal and Macular Surgery](https://scholariq.org/topics/retinal-and-macular-surgery/)
- [Ocular Diseases and Behçet’s Syndrome](https://scholariq.org/topics/ocular-diseases-and-behcet-s-syndrome/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.